Every 10-Q that Callan JMB Inc. (CJMB) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow CJMB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CJMB filings page.
Callan JMB Inc. reported lower revenue and higher losses for the three and six months ended June 30, 2026. Quarterly revenue was $1,376,326 and six‑month revenue was $2,482,468, down 17% and 20% from the prior-year periods, mainly from reduced demand for emergency preparedness services by state and local governments.
The company recorded a net loss of $1,231,923 for the quarter and $4,446,977 for the first half of 2026, a 68% larger loss year‑to‑date than in 2025. Cash and cash equivalents were $860,273 at June 30, 2026, with net cash used in operating activities of $2,075,943 for the six months. Total assets were $4,451,058 and stockholders’ equity declined to $681,863.
Management states that recurring losses, negative operating cash flows, a $14,706,991 accumulated deficit, and limited cash raise substantial doubt about the ability to continue as a going concern within one year. To support liquidity, the company is using a $25.0 million Equity Line of Credit, which generated $915,000 of net proceeds and 596,837 shares issued in the first half, and has established a $5.0 million at‑the‑market offering program with no sales to date.
Callan JMB Inc. reported a weaker first quarter of 2026 with revenue of $1,106,143, down 24% from the prior year, as a key government contract was not renewed and non-government sales declined. Gross profit fell to $427,235, while selling, general and administrative expenses rose 15% to $2,128,423, driven by higher payroll, new office rent, consulting and public-company costs.
The company’s net loss widened to $3,215,054 (loss of $0.59 per share) compared with $1,240,590 a year earlier, reflecting both operating losses and $1,177,223 of ELOC-related transaction expenses plus a $338,229 loss from changes in the fair value of its ELOC derivative liability.
At March 31, 2026, cash stood at $1,415,566 and stockholders’ equity was $1,599,533, below the $2,500,000 minimum required by Nasdaq. After quarter-end, Nasdaq notified the company of this equity deficiency. Management highlights access to an Equity Line of Credit with $23.45M remaining availability and ongoing support from its CEO as key liquidity sources, and believes its plans alleviate substantial doubt about continuing as a going concern over the next twelve months.
Callan JMB Inc. (CJMB) filed its Q3 2025 10‑Q reporting higher quarterly revenue but wider losses. Q3 revenue was $1,446,917 (vs. $1,435,376 a year ago), with gross profit of $493,307. Selling, general and administrative expenses rose to $2,372,465, driving an operating loss of $(1,879,158) and a net loss of $(2,731,341).
For the first nine months, revenue was $4,562,604 (vs. $5,211,665), and net loss expanded to $(5,373,327). Operating cash flow was $(3,887,737). Cash and cash equivalents were $2,789,744 at September 30, 2025. Governmental customers accounted for most sales, led by emergency preparedness at $973,921 in Q3.
The company completed an IPO in February, raising gross proceeds of about $5,776,000 (net ~$4,700,000), and established a $25,000,000 equity line of credit. Under the facility, ~123,208 shares were issued for net proceeds of ~$497,750, and a derivative liability of $624,041 was recorded. Shares outstanding were 4,623,027 as of September 30, 2025; as of November 14, 2025, 4,623,027 shares were issued and outstanding.